Skip to content

Clinical trials

Completed Phase 2 Immunoglobulin Light-chain Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Phase: Phase 2 Status: Completed Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20042
20052
20074
20083
20092
20102
20122
20132
20141
20161
20181
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Medical Center4
Mayo Clinic3
SWOG Cancer Research Network3
Barbara Ann Karmanos Cancer Institute2
Herbert Irving Comprehensive Cancer Center2
Memorial Sloan Kettering Cancer Center2
Alexion Pharmaceuticals, Inc.1
Boston University1
Case Comprehensive Cancer Center1
Columbia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis39
Multiple Myeloma23
Neoplasms, Plasma Cell14
Amyloidosis8
Leukemia, Lymphocytic, Chronic, B-Cell8
Burkitt Lymphoma7
Hodgkin Disease7
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular7
Lymphoma, Large B-Cell, Diffuse7

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.